Press News

Press News

Press News | 21.11.2025

Print:
Title Media Publ. Date
Adonis Georgiadis: Within the next 10 days the JMD on Clinical Trials Health Daily 20/11/2025
The year of significant tax relief Apogevmatini 21/11/2025
Entrepreneur Panos Marinopoulos has died Kathimerini 21/11/2025
Seasonal flu has “arrived” earlier in EU countries Kathimerini 21/11/2025
Room for €900 million in benefits in 2027 Kathimerini 21/11/2025
Isidoros Mentis: Competition policy and generics Naftemporiki 21/11/2025

 

See here the publicity

 

Web Monitoring Report for the period 20/11 – 21/11

Title Media Publ. Date
When should we take antibiotics and when not – What is antimicrobial resistance and why is it dangerous capital.gr 20/11/2025
Michael Himonas (SFEE): We need an innovation-driven mindset and a redefinition of pharmaceutical investment cnn.gr 20/11/2025
Theodoros Tryfon (PEF): Chronic underfunding leads to medicine shortages & the loss of productive capacity cnn.gr 20/11/2025
Ioannis Kotsiopoulos: Major changes in healthcare do not come spectacularly, but through consistency and cooperation cnn.gr 20/11/2025
Nikos Dedes: Illness brings awkwardness – All patient associations have experienced stigma cnn.gr 20/11/2025
Julia Tseti: Award for innovation and contribution to the pharmaceutical sector healthpharma.gr 20/11/2025
Significant delays in the digitization of medical records in hospitals — Risk of losing funds healthreport.gr 21/11/2025
Overdue debts: Hospitals are collapsing under the burden of EKAPY healthweb.gr 20/11/2025
Trump reduces the tariffs on medicines from Switzerland iatronet.gr 21/11/2025
Memi Tsekoura, new president of the BoD of the Greek Patients’ Association iatronet.gr 20/11/2025
Budget 2026: What measures it brings for the new year tovima.gr 20/11/2025

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.